Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Oct 18:15:310-319.
doi: 10.1016/j.ibneur.2023.10.005. eCollection 2023 Dec.

Exploring the effects of resveratrol supplementation on cerebrovascular function in hormonal migraineurs: A pilot study

Jemima S A Dzator  1   2 , Kirsten G Coupland  1   3 , Peter R C Howe  1   4   5
Affiliations

Exploring the effects of resveratrol supplementation on cerebrovascular function in hormonal migraineurs: A pilot study

Jemima S A Dzator et al. IBRO Neurosci Rep. .

Abstract

Background: Past research suggests that hormonal migraineurs may have poorer cerebrovascular function than women who do not suffer from migraine. Resveratrol, a vasoactive phytoestrogen, has been shown to improve cerebrovascular function in several populations but has never been tested in hormonal migraineurs.

Aim: To investigate the effects of 3-month resveratrol supplementation on the cerebrovascular function of hormonal migraineurs.

Methods: We conducted a randomised, double-blind, placebo-controlled, crossover intervention pilot study with resveratrol (150 mg/d for 3 months) in ten hormonal migraineurs (mean age: 37.2 ± 2.6 years). Participants visited the University of Newcastle's Clinical Nutrition Research Centre where quality of life and disability, and cerebrovascular function were assessed. Quality of life and disability were examined using Migraine-Specific Quality of Life, Headache Impact Test-6 and the Migraine Disability Assessment. Cerebrovascular function was determined using transcranial Doppler ultrasound to bilaterally measure blood flow velocity in the middle and posterior cerebral arteries at rest and in response to a hypercapnic stimulus. Cerebrovascular responsiveness to a cognitive task battery was also measured bilaterally in the middle cerebral arteries.

Results: Compared to placebo, blood flow velocity in the right posterior cerebral artery was significantly higher (P = 0.041) following resveratrol supplementation. No other significant differences in cerebrovascular function between resveratrol and placebo treatments were observed. Baseline correlation analyses revealed higher blood flow velocities in the middle and posterior cerebral arteries were associated with better quality of life and less disability. However, higher cerebrovascular responsiveness to hypercapnia in the posterior circulation was associated with higher migraine-related disability and poorer migraine-related quality of life.

Conclusion: In this pilot we found evidence that resveratrol may increase blood flow velocity in the right posterior cerebral artery in hormonal migraineurs. Larger cohorts are required confirm this effect and its potential relationship to migraine in premenopausal women.

Keywords: Cerebral blood flow; Cerebrovascular function; Hormonal migraine; Neurovascular coupling.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Study flow of participants who were able to visit the research centre for cerebrovascular function testing.
gr2
Fig. A1: Significant correlations between cerebrovascular function parameters in the left MCA and migraine-related quality of life/disability.
gr3
Figure 2: Significant correlations between cerebrovascular function parameters in the left PCA and migraine-related quality of life/disability.
gr4
Figure 3: Significant correlations between cerebrovascular function parameters in the right MCA and PCA and migraine-related quality of life/disability.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Altamura C., Paolucci M., Brunelli N., Cascio Rizzo A., Cecchi G., Assenza F., et al. Right-to-left shunts and hormonal therapy influence cerebral vasomotor reactivity in patients with migraine with aura. PLoS One. 2019;14(8) - PMC - PubMed
    1. Altman D.G., Bland J.M. Treatment allocation by minimisation. Bmj. 2005;330(7495):843. - PMC - PubMed
    1. Bowers J.L., Tyulmenkov V.V., Jernigan S.C., Klinge C.M. Resveratrol acts as a mixed agonist/antagonist for estrogen receptors α and β. Endocrinology. 2000;141(10):3657–3667. - PubMed
    1. Diomedi M., Cupini L.M., Rizzato B., Ferrante F., Giacomini P., Silvestrini M. Influence of physiologic oscillation of estrogens on cerebral hemodynamics. J. Neurol. Sci. 2001;185(1):49–53. - PubMed
    1. Dzator J.S.A., Howe P.R.C., Griffiths L.R., Coupland K.G., Wong R.H.X. Cerebrovascular function in hormonal migraine: an exploratory study. Front. Neurol. 2021;12 - PMC - PubMed

LinkOut - more resources